List of insiders holdings for NEKTAR THERAPEUTICS:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Deep Track Capital LP Deep Track Biotechnology Master Fund Ltd. KROIN DAVID 10% Owner |
2025-02-14 08:43:38 | 1,975,998 0 |
1,975,998 | Form 13G |
2 | ROBIN HOWARD W President & CEO |
2025-02-21 18:04:25 | 1,086,901 410 |
1,087,311 | Form 4 |
3 | HARRIS J MILTON President of Nektar AL |
2004-03-19 21:07:22 | 0 743,904 |
743,904 | Form 4/A |
4 | Wilson Mark Andrew Chief Legal Officer |
2025-02-21 18:06:43 | 324,292 0 |
324,292 | Form 4 |
5 | Zalevsky Jonathan Chief R&D Officer |
2025-02-21 18:07:52 | 316,604 0 |
316,604 | Form 4 |
6 | PATTON JOHN STUART Chief Scientific Officer |
2008-11-18 15:11:07 | 313,880 0 |
313,880 | Form 4 |
7 | Thomsen Jillian B. Chief Financial Officer |
2023-02-17 20:58:41 | 313,497 0 |
313,497 | Form 4 |
8 | Labrucherie Gil M SVP, COO & CFO |
2022-05-17 21:32:02 | 312,905 0 |
312,905 | Form 4 |
9 | NORTHCOTT JOHN SVP & Chief Commercial Officer |
2022-05-17 21:33:45 | 223,210 0 |
223,210 | Form 4 |
10 | HARKNESS TIMOTHY SVP & Chief Financial Officer |
2007-09-21 17:48:19 | 200,000 0 |
200,000 | Form 4/A |
11 | Nicholson John SVP & Chief Operating Officer |
2019-08-19 19:07:55 | 162,759 0 |
162,759 | Form 4 |
12 | GLAVIN JAMES B Director |
2003-09-05 18:01:27 | 149,600 0 |
149,600 | Form 4 |
13 | PERELMAN MELVIN Director |
2004-09-03 13:08:23 | 147,500 0 |
147,500 | Form 4 |
14 | CHESS ROBERT Director |
2025-01-17 20:35:06 | 120,000 0 |
120,000 | Form 5 |
15 | Brainard Diana Director |
2025-01-17 20:32:48 | 120,000 0 |
120,000 | Form 5 |
16 | Ajer Jeffrey Robert Director |
2025-01-17 20:30:39 | 120,000 0 |
120,000 | Form 5 |
17 | GREER R SCOTT Director |
2025-01-17 20:37:24 | 120,000 0 |
120,000 | Form 5 |
18 | WHITFIELD ROY A Director |
2025-01-17 20:39:20 | 120,000 0 |
120,000 | Form 5 |
19 | Curet Myriam Director |
2023-09-20 20:09:30 | 112,418 0 |
112,418 | Form 4 |
20 | Doberstein Stephen K SVP & Chief Scientific Officer |
2019-09-09 17:09:44 | 107,668 0 |
107,668 | Form 4 |
21 | Gergel Ivan P. SVP & Chief Medical Officer |
2017-11-17 18:03:51 | 106,553 0 |
106,553 | Form 4 |
22 | Krivulka Joseph J Director |
2017-09-21 16:46:21 | 104,500 0 |
104,500 | Form 4 |
23 | CHOWRIRA BHARAT M Chief Operating Officer |
2010-02-03 12:00:07 | 100,000 0 |
100,000 | Form 4 |
24 | Ghosh Rinko Chief Business Officer |
2013-02-08 16:13:45 | 100,000 0 |
100,000 | Form 4 |
25 | Hora Maninder SVP Pharma Dev & Mfg Ops |
2019-05-17 20:19:53 | 94,694 0 |
94,694 | Form 4 |
26 | GILL AJIT President & CEO |
2006-03-24 18:15:08 | 0 87,991 |
87,991 | Form 4 |
27 | Elam Nevan C SVP & Head of Pulmonary Bus |
2008-02-27 19:38:59 | 85,000 0 |
85,000 | Form 4 |
28 | Moreadith Randall W SVP Drug Development |
2009-02-25 12:15:21 | 85,000 0 |
85,000 | Form 4 |
29 | Lorianne Masuoka K. Chief Medical Officer |
2011-02-10 16:56:49 | 75,000 0 |
75,000 | Form 4 |
30 | WINGER DENNIS L Director |
2018-08-21 19:32:27 | 57,750 5,000 |
62,750 | Form 4 |
31 | KUEBLER CHRISTOPHER A Director |
2018-10-01 20:23:50 | 54,750 0 |
54,750 | Form 4 |
32 | WANG SUSAN Director |
2015-11-20 17:27:10 | 54,128 0 |
54,128 | Form 4 |
33 | Lingnau Lutz Director |
2020-09-25 20:14:42 | 54,000 0 |
54,000 | Form 4/A |
34 | EASTHAM KARIN Director |
2022-09-20 20:47:33 | 43,633 0 |
43,633 | Form 4 |
35 | Medve Robert SVP & Chief Medical Officer |
2014-02-07 13:46:41 | 25,000 0 |
25,000 | Form 4 |
36 | BROWN MICHAEL A Director |
2009-09-17 18:08:16 | 20,000 0 |
20,000 | Form 4 |
37 | Huh Hoyoung Director |
2008-12-04 16:29:12 | 20,000 0 |
20,000 | Form 4 |
38 | LERNER IRWIN Director |
2008-12-04 16:26:05 | 20,000 0 |
20,000 | Form 4 |
39 | Johnston David SVP, Research & Development |
2007-05-15 10:30:16 | 14,600 0 |
14,600 | Form 4 |
40 | DRAPEAU LOUIS Sr. VP Finance, CFO |
2007-05-14 15:19:51 | 6,000 0 |
6,000 | Form 4 |
41 | BANSAL AJAY Former CFO |
2006-03-13 14:35:32 | 5,166 0 |
5,166 | Form 4 |
42 | GARDINER SANDRA A. Chief Financial Officer |
2023-04-25 21:03:08 | 0 0 |
0 | Form 3 |